Sopharma Overview

  • Founded
  • 1933

Founded
  • Status
  • Public

  • Employees
  • 5,507

Employees
  • Stock Symbol
  • SFA

Stock Symbol
  • Investments
  • 23

  • Share Price
  • $2.25

  • (As of Friday Closing)

Sopharma General Information

Description

Sopharma AD-Sofia is a producer, exporter, and distributor of pharmaceutical products. It is engaged in the production of pharmaceutical products including medicines, primarily generics, herbal-based substances, and food supplements. It is also focused on the distribution of pharmaceuticals like medical supplies, sanitary materials, vitamins, food supplements, and cosmetics. The company operates in Bulgaria and internationally.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Pharmaceuticals
Stock Exchange
XBUL
Primary Office
  • 16 Iliensko shose Street
  • Sofia, 1220
  • Bulgaria
+359 0700 00 000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sopharma Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$2.25 $2.23 $2.19 - $2.80 $273M 121M 28.9K $0.46

Sopharma Financials Summary

In Thousands,
USD
TTM 30-Jun-2022 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019
EV 451,667 492,509 467,166 470,959
Revenue 944,985 965,902 835,216 730,853
EBITDA 96,529 94,601 49,784 78,866
Net Income 57,754 53,916 17,301 49,610
Total Assets 646,959 695,081 778,329 670,572
Total Debt 149,049 186,048 243,576 219,237
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Sopharma Patents

Sopharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3952845-A1 Oral pharmaceutical composition with a plant alkaloid for treatment of dependencies Pending 12-Apr-2019 0000000000
AU-2019440193-A1 Oral pharmaceutical composition with a plant alkaloid for treatment of dependencies Pending 12-Apr-2019 0000000000
CA-3126725-A1 Oral pharmaceutical composition with a plant alkaloid for treatment of dependencies Pending 12-Apr-2019 0000000000
US-20210275460-A1 Oral pharmaceutical composition with a plant alkaloid for treatment of dependencies Pending 12-Apr-2019 0000000000 0
US-11384080-B2 Method for isolation of cytisine Active 29-Jan-2018 C07D471/18 0
To view Sopharma’s complete patent history, request access »

Sopharma Executive Team (5)

Name Title Board Seat Contact Info
Boris Borisov Chief Financial Officer
Stoycho Pangev Chief Operating Officer
S. Donev Director, Business Development
Pelagia Viatcheva Director, Investor Relations
Ognian Donev Ph.D Chairman of the Board of Directors and Executive Director
To view Sopharma’s complete executive team members history, request access »

Sopharma Board Members (1)

Name Representing Role Since
000000 00000 00.0 Sopharma Chairman of the Board of Directors and Executive Director 000 0000
To view Sopharma’s complete board members history, request access »

Sopharma Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sopharma Investments & Acquisitions (23)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000 28-Dec-2020 000000000 Distributors (Healthcare)
00000000 19-Sep-2017 000000000 Pharmaceuticals
000000 09-Aug-2017 0000000000 Pharmaceuticals
00000000 21-Jul-2017 0000000000 Drug Discovery
RAP Pharma International 18-Apr-2017 Merger/Acquisition Distributors (Healthcare)
You’re viewing 5 of 23 investments and acquisitions. Get the full list »

Sopharma Subsidiaries (5)

Company Name Industry Location Founded
Aromania Drug Discovery Sofia, Bulgaria 2015
00000000 Pharmaceuticals Sofia, Bulgaria 0000
000000 Pharmaceuticals Sofia, Bulgaria 0000
00000000 Pharmaceuticals Uman, Ukraine 0000
0000 000000 Pharmaceuticals Veliko Tarnovo, Bulgaria 0000
To view Sopharma’s complete subsidiaries history, request access »

Sopharma Exits (5)

Company Name Exit Date Exit Type Exit Size Status Buyers
0000 28-Dec-2020 000000000 00000000 Completed
  • 00000000
0000 03-Dec-2013 000000000 00000000 Completed
  • 00000000
0000 10-Nov-2009 000000000000000000 Completed
  • 00000000
0000000 0 000000 31-Mar-2008 000000000000000000 Completed
  • 00000000
Sopharma Zdrovit 27-Sep-2007 Joint Venture Completed
  • 2 buyers
To view Sopharma’s complete exits history, request access »